Reich W. The spectrum concept of schizophrenia. Problems for diagnostic practice. // Arch Gen Psychiatry. – 1975. – Vol.32. – № .4.– P.489-498.
Rickel K., Schweizer E. Clinical overview of serotonin reuptake inhibitors. // J. Clin. Psychiatry –1990. — Vol.51. -№ 12. –Suppl. B. — P.9-12.
Rickelman B. L. Anosognosia in individuals with schizophrenia: toward recovery of insight. // Issues Ment Health Nurs. – 2004. – Vol.25. – № .3. – P.227-242.
Riker R. R., Fraser G. L., Cox P. M. Continuous infusion of haloperidol controls agitation in critically ill patients. // Crit Care Med. – 1994. – Vol.22. – № .3. – P.433-440.
Roose S. P. Depression, anxiety, and the cardiovascular system: the psychiatrist's perspective. // J Clin Psychiatry. – 2001. – Vol.62. – Suppl.8. – P.19-22.
Rosenthal D. Discussion: the concept of subschizophrenic disorders. // In: genetic research in psychiatry. Univ. Press. Baltimore,1975. — P.199-208.
Rosenthal D. The spectrum concept in schizophrenic and manic-depressive disorders. // Res Publ Assoc Res Nerv Ment Dis. – 1975. – Vol.54. – P.19-25.
Rousseau // Цит. Каннабих Ю. В. — Сов. невропатол. психиатр, и психогиг., 1934, т. 3, № 5, с. 6—13.
Ruskin P. E. Geropsychiatric consultation in a university hospital: a report on 67 referrals. // Am J Psychiatry. – 1985. – Vol.142. – № .3. – P.333-336.
Saito E., Correll C. U., Gallelli K., McMeniman M., Parikh U. H., Malhotra A. K., Kafantaris V. A prospective study of hyperprolactinemia in children and adolescents treated with atypical antipsychotic agents. // J Child Adolesc Psychopharmacol. – 2004. – Vol.14. – № .3. – P.350-358.
Sandberg O., Gustafson Y., Brannstrom B., Bucht G. Clinical profile of delirium in older patients. // J Am Geriatr Soc. – 1999. – Vol.47. – № .11. – P.1300-1306.
Sass H. The Historical evolution of the concept of negative symptoms in schizophrenia. // Brit. J. of Psychiatry. – 1989. – Vol.155. – Suppl.7. – P.29-31.
Schafer R. The clinical application of psychological tests. // NY, Int. Univ. Press. – 1948. – P.218-223.
Schatzber A. F., DeBattista Ch., Ereshefsky L., et al. Current psychotropic dosing and monitoring guidelines. // Primary psychiatry – 1997. — Vol.4 — P.35-60.
Schneider K. Die psychopatischen Persönlichkeiten. // Deuticke, Leipzig — Wien: 1928. — 87S.
Schneider K. Klinische Psychopathologie. Stuttgart, 1943.
Schwartz T. L., Masand P. S. Treatment of Delirium With Quetiapine. // Prim Care Companion J Clin Psychiatry. – 2000. – Vol.2. – № .1. – P.10-12.
Selye H. The evolution of the stress concept. // Am Sci. – 1973. – Vol. 61. – № .6. – P.692-699.
Serban G, Siegel S. Response of borderline and schizotypal patients to small doses of thiothixene and haloperidol. // Am J Psychiatry. –1984. – Vol.141. – № .11. – P.1455-1458.
Settle E. C., Ayd F. J. Haloperidol: a quarter century of experience. // J Clin Psychiatry. – 1983. – Vol.44. – № .12. – P.440-448.
Siever L. J., Davis K. L. The pathophysiology of schizophrenia disorders: perspectives from the spectrum. // Am J Psychiatry. – 2004. – Vol.161. – № .3. – P.398-413.
Singh A. N. Pharmacological therapy in psychosomatic medicine. // Shinshin-Igaku. –1992. — Vol.32. — P.589-598.
Sipahimalani A., Masand P. S. Use of risperidone in delirium: case reports. // Ann Clin Psychiatry. – 1997. – Vol.9. – № .2. – P.105-107.
Sipahimalani A., Masand P. S. Olanzapine in the treatment of delirium. // Psychosomatics. – 1998. – Vol.39. – № .5. – P.422-430.
Skrobik Y. K., Bergeron N., Dumont M., Gottfried S. B. Olanzapine vs. haloperidol: treating delirium in a critical care setting. // Intensive Care Med. – 2004. – Vol.30. – № .3. – P.444-449.
Smith G. C., Clarke D. M., Handrinos D., Dunsis A. Consultation-liaison psychiatrists management of depression. // Psychosomatics –1998. –Vol.39. — № 3. –P.244-252.
Sommer R. Zur Diagnostik der Geisteskrankheiten. Leipzig, 1894.
Spitzer R., Endicott J. Crossing border into borderline personality and borderline schizophrenia. // Arch. Gen. Psychiat. – 1979. – Vol.36. – P.17-24.
Stahl S. M. Selecting an atypical antipsychotic by combining clinical experience with guidelines from clinical trials. // J Clin Psychiatry. –1999. – Vol.60. – Suppl. 10. – P.31-41.
Stengel E. — Arch. Psychiat. Nervenkr., 1937, Bd 10, S. 509—553.
Stephens J. H., Astrup C., Mangrum J. C. Prognostic factors in recovered and deteriorated schizophrenics. // Am. J. Psychiat. – 1963. – Vol.119. – P.945—953.
Stern T. A. Management of depression and anxiety following myocardial infarction. // Mt. Sinai J. Med. – 1985. – Vol. 52. –P.623-633.
Szigethy E. M., Schulz S. C. Risperidone in comorbid borderline personality disorder and dysthymia. // J Clin Psychopharmacol. – 1997. – Vol.17. – № .4. – P.326-327.
Tandon R. Safety and tolerability: how do newer generation «atypical» antipsychotics compare? // Psychiatr Q. – 2002. – Vol.73. – № .4. – P.297-311.
Torres R., Mittal D., Kennedy R. Use of quetiapine in delirium: case reports. // Psychosomatics. – 2001. – Vol.42. – № .4. – P.347-349.
Trimble M. R. Positive and negative symptoms in psychiatry. // Brit. J. of Psychiatry. – 1986. – Vol.148. – P.587-589.
Triozzi P. L., Goldstein D., Laszlo J. Contributions of benzodiazepines to cancer therapy. // Cancer Investigation –1988. – Vol.6. — № 1. – P.103-111.
Tsuang M. T., Stone W. S., Faraone S. V. Schizoaffective and schizotypal disorders. // New Oxford Textbook of Psychiatry. – 2000. – Vol.1. – P.636-644.
Tune L. The role of antipsychotics in treating delirium. // Curr Psychiatry Rep. – 2002. – Vol. 4. – № .3. – P.209-212.
Uchiyama M., Tanaka K., Isse K., Toru M. Efficacy of mianserin on symptoms of delirium in the aged: an open trial study. // Prog Neuropsychopharmacol Biol Psychiatry. – 1996. – Vol.20. – № .4. – P.651-656.
van Hemert A. M., van der Mast R. C., Hengeveld M. W., Vorstenbosch M. Excess mortality in general hospital patients with delirium: a 5-year follow-up of 519 patients seen in psychiatric consultation. // J. Psychosom. Res. – 1994. – Vol.38. – № .4. – P.339—346.
van Leeuwen A. M., Molders J., Sterkmans P., Mielants P., Martens C., Toussaint C., Hovent A. M., Desseilles M. F., Koch H., Devroye A., Parent M. Droperidol in acutely agitated patients. A double-blind placebo-controlled study. // J Nerv Ment Dis. – 1977. – Vol.164. – № .4. – P.280-283.
van der Molen-Eijgenraam M., Blanken-Meijs J. T., Heeringa M., van Grootheest A. C. Delirium due to increase in clozapine level during an inflammatory reaction. // Ned Tijdschr Geneeskd. – 2001. – Vol.145. – № .9. – P. 427-430.
Wernicke К. // Цит. по: Руководство по психиатрии (в 2-х томах). Под ред. А. С. Тиганова. М., 1999
Wilkins-Ho M., Hollander Y. Toxic delirium with low-dose clozapine. // Can J Psychiatry. – 1997. – Vol. 42. – № .4. – P.429-430.
Wilmans K. Nervenheilt und Psych. – 1907. – Bd.30. – № .18. – S.569-579.
Wilt J. L., Minnema A. M., Johnson R. F., Rosenblum A. M. Torsade de pointes associated with the use of intravenous haloperidol. // Ann Intern Med. – 1993. – Vol.119. – № .5. – P.391-394.
Workman R. H. Jr., Orengo C. A., Bakey A. A., Molinari V. A., Kunik M. E. The use of risperidone for psychosis and agitation in demented patients with Parkinson's disease. // J Neuropsychiatry Clin Neurosci. –1997. – Vol. 9. – № .4. – P.594-597.
Yeragani V. K., Pesce V., Jayaraman A., Roose S. Major depression with ischemic heart disease: effects of paroxetine and nortriptyline on long-term heart rate variability measures. // Biol Psychiatry. – 2002. – Vol.52. – № .5. –P.418-429.
Yeragani V. K., Roose S., Mallavarapu M., Radhakrishna R. K., Pesce V. Major depression with ischemic heart disease: effects of paroxetine and nortriptyline on measures of nonlinearity and chaos of heart rate. // Neuropsychobiology. – 2002. – Vol.46. – № .3. – P.125-135.
Zarate C. A., Baldessarini R. J., Siegel A. J., Nakamura A., McDonald J., Muir-Hutchinson L. A., Cherkerzian T., Tohen M. Risperidone in the elderly: a pharmacoepidemiologic study. // J Clin Psychiatry. –1997. – Vol. 58. – № .7. – P.311-317.
Zilboorg G. The problem of ambulatory schizophrenias. // Am. J. Psychiat. – 1956. – Vol.113. – P. 519—525.
Zohar J. Treatment of obsessive-compulsive syndromes in schizophrenia. // CNS Spectrums. – 1997. – Vol.2. – № .4. – P.34-45.
